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Abstract
Background: Elderly persons admitted to the hospital are at risk for hospital related functional loss. This evaluation
aims to compare the effects of different levels of (integrated) health intervention care programs on preventing
hospital related functional loss among elderly patients by comparing a new intervention program to two usual
care programs.
Methods/Design: This study will include an effect, process and cost evaluation using a mixed methods design of
quantitative and qualitative methods. Three hospitals in the Netherlands with different levels of integrated geriatric
health care will be evaluated using a quasi-experimental study design. Data collection on outcomes will take place
through a prospective cohort study, which will incorporate a nested randomised controlled trial to evaluate the
effects of a stay at the centre for prevention and reactivation for patients with complex problems. The study
population will consist of elderly persons (65 years or older) at risk for functional loss who are admitted to one of
the three hospitals. Data is prospectively collected at time of hospital admission (T0), three months (T1), and twelve
months (T2) after hospital admission. Patient and informal caregiver outcomes (e.g. health related quality of life,
activities of daily living, burden of care, (re-) admission in hospital or nursing homes, mortality) as well as process
measures (e.g. the cooperation and collaboration of multidisciplinary teams, patient and informal caregiver
satisfaction with care) will be measured. A qualitative analysis will determine the fidelity of intervention
implementation as well as provide further context and explanation for quantitative outcomes. Finally, costs will be
determined from a societal viewpoint to allow for cost effectiveness calculations.
Discussion: It is anticipated that higher levels of integrated hospital health care for at risk elderly will result in
prevention of loss of functioning and loss of quality of life after hospital discharge as well as in lower burden of
care and higher quality of life for informal caregivers. Ultimately, the results of this study may contribute to the
implementation of a national integrated health care program to prevent hospital related functional loss among
elderly patients.
Trial registration: The Netherlands National Trial Register: NTR2317
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Background
Hospital admission is considered a risk (especially for
older patients), which increases with age [1]. Among 70-
year olds who are admitted in the hospital, 35% show
functional loss at time of discharge when compared to
the period before hospital admission, and this percen-
tage rises as high as 65% for persons aged 90 years or
older [2]. Hospital related functional loss among elderly
is often associated with the risk of developing complica-
tions due to an illness or its treatment [1]. Nevertheless,
functional loss among elderly persons is only partly the
result of the patient’s diagnosed illness at admission and
treatment thereof [2], implicating that a hospital stay by
itself leads to functional loss as well. Functional loss
may lead to renewed hospital admission, prolonged hos-
pital stay, admission in a nursing home or even early
death [3,4]. Furthermore, it will lead to greater depen-
dence, resulting in a higher burden of care for informal
caregivers [2,5-7], higher utilization of professional
health care and thus higher health care costs [8]. It is
therefore important to prevent or reduce functional loss
among elderly at an early stage [9].
Risk factors for functional loss are highly prevalent
among elderly patients at time of hospital admission
[10] and can be categorized into several domains: 1)
physical status (e.g. age, functioning prior to admission
to hospital, diagnosis, co-morbidities, low Body Mass
Index/malnutrition, tendency to fall); 2) mental status
(e.g. cognitive problems, delirium, depression, anxiety);
3) socio-economic situation (e.g. financial environment)
and social environment (e.g. living arrangements prior
to admission) as well as aspects regarding care such as
poly pharmacy [2,5,8,11-21]. Even though functional loss
is a recurrent problem among hospitalised elderly
patients, hospital care is usually primarily focused on
treating the medically diagnosed illness, thereby often
neglecting reactivation care that may prevent functional
loss. A “paralleled focused” treatment on reactivation
treatment next to treatment of medical diagnosis may
preserve functioning of the elderly patient at risk,
thereby possibly maintaining quality of life and indepen-
dence in activities of daily living in the period after dis-
charge from the hospital, which in turn may lead to a
lower burden of care for the informal caregivers of these
patients as well as lower health care costs at a societal
level. This article describes the study design (e.g. meth-
ods, setting, population, strengths, and weaknesses) of
an evaluation study of a hospital based reactivation care
program that is developed to provide reactivation care
parallel with regular medical care. This new intervention
program will be further referred to in this article as “the
program” and will be compared to two control hospitals
offering different levels of usual care.
Description of the hospital based reactivation
care program
The program is developed to prevent and/or reduce
hospital related functional loss among at risk elderly by
offering an individualized treatment plan that is based
on problem-solving principles. It includes interventions
that are integrated, multidisciplinary and goal-oriented
at physical, social, and psychological domains of func-
tional loss and combines existing treatment methods
and routes for reactivating at risk elderly persons into
an individual care package.
The program consists of several important elements:
First, it aims to identify elderly persons at risk for func-
tional loss at an early stage after hospital admission
(= triage within 48 hours of admission). This will make
early implementation of interventions possible, which
may prevent functional decline and promote a quick
return to independent living as well as preserve quality
of life [7,22]. Second, the program consists of a combi-
nation of integrated interventions offered by a specia-
lized multidisciplinary reactivation team with geriatric
expertise. Based on existing literature, this approach is
expected to lead to reductions in fall incidence,
improved functioning, reduced length of hospital stay,
lower (re)admissions to hospital and nursing homes,
improved mental well-being of informal caregivers and
higher perceived health and life satisfaction among
patients as well as better coordination of treatment and
follow up between different health care providers and
finally, lower mortality [23-34]. Third, the multidisci-
plinary team uses Goal Attainment Scaling (GAS) to
develop and monitor a personalized treatment plan. The
GAS method has been successful in maintaining/
improving functioning of elderly patients with complex
health issues [35,36] and has been standardized for this
population [37]. The GAS method consists of several
phases: The multidisciplinary team identifies the base-
line status of the patient and determines a goal. Then
the team will monitor the development per patient and
their informal care system by measuring progress regu-
larly, making it possible to adjust interventions and/or
goals when necessary. A final GAS measurement will
take place to set up a follow up treatment plan before
the patient is discharged to the home environment. The
fourth element of the program is the possibility for
patients with complex problems to be referred by the
multidisciplinary team to a stay at a specialized centre
for prevention and reactivation (further referred to in
this article as “the reactivation centre” or “the centre”).
The centre offers a combination of interventions aimed
at improving a patient’s ability to live as independently
as possible in the home environment by providing
extra-intensive thematic reactivation treatment alongside
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regular provisions. It includes specialized nursing home
care, paramedical care, specialized mental health care,
and treatment and consultations for primary informal
caregivers if needed. Patients stay at the reactivation
centre for a maximum of three months, after which the
multidisciplinary team will develop an individual care-
plan for follow up after discharge. Finally, the program
will provide support to patients and their informal care-
givers by means of a case manager with geriatric exper-
tise who is involved in all aspects of care throughout the
period of hospital stay as well as during the follow up
period after hospital discharge (irrespective of a patient’s
destination after discharge whether this is their indepen-
dent home, the centre for prevention and recovery, a
nursing home or any other setting). The case manager
is involved in identifying at risk patients in the hospital,
coordinating the individual’s care plan, coordinating fol-
low up health care for a patient after discharge (e.g. in
cooperation with general practitioner, home care or
other first line care providers) and aims to support and
motivate the patient in treatment adherence. In addition
the case manager monitors a patient’s risk factors for
functional loss throughout all phases of care and may
plan extra treatment if necessary as well as improve the
care process where possible. Previous programs focused
on case management or follow up care have lead to
reductions in hospital admissions, nursing home admis-
sions as well as a reduction in length of hospital stay
[38,39]. Furthermore, case management may lead to
improved access to health care, increased psychosocial
support and improved communication with health pro-
fessionals as valued by patients and their informal care-
givers [40].
Even though earlier studies have shown the benefits of
specialized multidisciplinary geriatric inpatient reactiva-
tion interventions (as well as similar programs for
elderly persons living at home), insufficient data is avail-
able on programs offering a combination of abovemen-
tioned successful elements of care, their cost-
effectiveness, and on how to define the patient group
that benefits the most from these programs [39,41-45].
To our knowledge, the current evaluation of the new
intervention program is the first to offer results on the
effects of a combination of several successful elements
of care as well as offer clear patient eligibility criteria for
such an integrated program.
Objectives of the evaluation
This evaluation study entails an effect, process and cost
evaluation of offered geriatric health care and has four
main objectives. First of all, the study aims to determine
to what extent the program, in comparison with other
usual forms of geriatric care, leads to a retention in
functioning and quality of life of at risk elderly, a
reduction in the burden of care for the patient’s primary
informal caregiver, shorter lengths of hospital stay, and
a reduction of ‘wrong bed’ problems as well as (re-)
admission to hospitals, nursing homes and mortality. In
addition, it will show the extent to which program care
including a stay at a reactivation centre, leads to better
functioning and quality of life of elderly patients in need
of complex care. Secondly, the study aims to determine
to what extent the triage instruments used in the pro-
gram detect increased risk for functional loss and to
determine how criteria for triage should be adjusted to
optimally link the offered interventions to the needs of
the individual elderly at risk. Thirdly, the evaluation will
determine to what extent the program, in comparison
with other, usual forms of geriatric care in the Nether-
lands, leads to a better structure and process of care.
Finally, the cost-effectiveness of the program (both
including and excluding a stay at a reactivation centre)
will be determined in comparison with other usual
forms of geriatric hospital care in the Netherlands.
Methods/Design
Evaluation design
This evaluation study uses a concurrent mixed methods
design (a combination of qualitative and quantitative
research methods) to evaluate triage criteria, effects,
processes and costs of the care provided in the three
hospitals. It consists of a quasi-experimental study as
well as a nested randomised controlled trial. Within the
quasi-experimental study, the data collection of health
care costs and outcomes on functional status and quality
of life for patient and caregiver as well as other outcome
measures such as cognitive functioning, duration of hos-
pital stay and mortality of patients will be measured
using a prospective cohort design. The “reactivation
centre” component will be evaluated using a randomised
controlled trial. Patients eligible for a stay at the reacti-
vation centre will be randomised to program treatment
with a stay at the centre or program treatment without
a stay at the centre. The effects of a stay in the reactiva-
tion centre will be measured at three months after hos-
pital admission and the effects of a centre stay in
combination with program aftercare at home will be
evaluated at twelve months after hospital admission. In
addition, a set of quantitative process indicators will be
collected both for program treatment with and without
a stay at the centre (e.g. which disciplines were involved
in treatment, how soon after admission the treatment
started). For an in-depth evaluation of the effects of the
program, data is collected on the differences in the
healthcare processes between the three hospitals as well
as differences in offered follow up care between the
three hospitals. Qualitative data will be collected
through interviews, observations and document analysis
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at similar times as the effect evaluation. These qualita-
tive measures will support the comparison of the quality
of care processes between the three hospitals.
The study protocol was approved by the medical
ethics committee of the Erasmus Medical Centre, Rot-
terdam, the Netherlands, under protocol number
MEC2011-041.
Setting
Three hospitals with different levels of geriatric care will
be compared in this evaluation. The first hospital
(Ruwaard van Putten, Spijkenisse) offers care without
clinical geriatrics, with hospital replacement care
through a care hotel and no follow up in primary care.
The second hospital (St. Franciscus Gasthuis, Rotter-
dam) offers care with coordinated discharge and hospital
replacement care (through care hotel “Aafje”) and with-
out follow up in primary care. The third hospital (Vliet-
land + Argos Zorggroep, Nieuwe Waterweg, Noord) is
the intervention hospital and offers the new hospital
based reactivation care program which includes clinical
geriatrics, intensive reactivation care after hospital stay
(through a stay at the centre for prevention and reacti-
vation) and with follow up in primary care (through
case management). The three hospitals have been cho-
sen as they are similar in patient case mix as well as
offer geriatric care in different dosages and with differ-
ent elements of care.
Pilot study
A pilot study was conducted in the intervention hospital
(Vlietland hospital) to choose the best triage instru-
ments to identify elderly patients eligible for the reacti-
vation program. Furthermore, the pilot results will be
used to identify possible practical implementation pro-
blems in preparation for the main evaluation study and
serve as base for power calculations for the main study.
In the pilot study, all patients (65 years or older) who
were admitted to the Vlietland hospital between June
2010 and October 2010, were asked to participate.
Around 500 patients and 200 informal caregivers were
included at baseline (within 48 hours after hospital
admission) and of this group around 300 patients and
160 informal caregivers completed questionnaires at the
3-month follow up (see figure 1: Flow chart pilot study).
Follow up measurements at twelve months after hospital
admission will be finalized in November/December
2011.
Participants
Population
The target population of the study consists of elderly
persons (65 years and older) who are at risk for func-
tional loss and are admitted to one of the three hospitals
for at least two days. All patients will receive the usual
care offered by each of the hospitals. All relevant hos-
pital departments will be included in the study and
admission may be elective or acute. Figures 2 and 3
(flowcharts) provide an overview of the flow of patients
in the study. Through a first triage step, all patients at
risk for functional loss will be identified with the ISAR-
HP [46,47]. These at risk patients will be eligible to
receive the hospital based reactivation care program and
therefore will be asked to participate in the study. In the
Vlietland hospital, an additional triage will take place
using the short Neuropsychiatric Inventory [48,49] and
the Mini Mental State Examination [50] to identify
elderly patients eligible for a stay at the reactivation cen-
tre. This group will then be randomised to program care
including a stay at the centre (n = 200) or program care
excluding a stay at the centre (n = 200). The primary
informal caregivers of the participating patients will be
asked to answer several questions about the patient in a
telephone interview as well as fill out mailed paper
questionnaires on quality of life, burden of care and
other outcomes at time of hospital admission of the
patient, three months after hospital admission and
twelve months after hospital admission. Furthermore,
health care professionals from each participating hospi-
tal will be asked to complete a survey on processes of
health care.
Inclusion criteria
• patients aged 65 years or older
• admitted in one of the participating hospitals and
staying >48 hours
• at risk for functional loss (ISAR HP ≥ 1)
Additional criteria for a stay at the centre for preven-
tion and recovery
• ISAR HP ≥ 2 and/or MMSE ≤ 27 and/or NPI ≥ 3
Exclusion criteria
• Unable to answer questions or follow instructions
(e.g. due to severe cognitive problems (MMSE score
<12/delirium/coma) within 48 hours of admission in
the hospital
• Not able to understand the Dutch language
• Life expectancy <3 months.
Power calculation and effect size
For the prospective cohort we expect to be able to col-
lect a sample size of around 1100 patients in the inter-
vention hospital (900 patients treated with the new
intervention program and 200 patients treated with the
new intervention program including a stay at the reacti-
vation centre). Samples of minimal 500 to 600 patients
will be collected in each of the two control hospitals.
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These estimations are based on the average number of
elderly patients who are admitted to the different hospi-
tals during our inclusion period of one year. According
to preliminary pilot results on activities of daily living
(Katz-15 ADL score), a population of n = 500 in the
control hospitals will lead to around n = 300 persons
analyzable at three months, whereas a baseline popula-
tion of n = 1100 in the intervention hospital will lead to
around 733 persons analyzable at three months. Using
an effect size of 0.25 this will lead to a power of 95%
[46]. Furthermore, to detect a smaller effect size
(Cohen’s D of 0.2), n = 1100 in the intervention hospital
and n = 500 for the control hospitals will lead to a
power of 83%. If possible, we will aim for a larger sam-
ple size in the control hospitals than the expected n =
500, (preferably 900), which will lead to N = 733 analyz-
able in the intervention hospital versus n = 600 analyz-
able in the control hospitals, with an effect size of 0.2
leading to a power of 95%. Abovementioned sample
sizes are large enough to allow for reliable analysis per
subgroup (e.g. subgroup of specific diagnoses) and sets
of risk factors.
Randomisation
Dynamic randomisation will be used to select patients
who receive the new program treatment. It is estimated
that the population of patients eligible for the program
will be higher than the actual amount of patients that
can be treated with the program due to restrictions on
available personnel, materials and budget. Therefore,
randomisation criteria will change dependent on what is
logistically possible (= dynamic). Since the reactivation
centre has a maximum capacity of 200 patients per year
at this time, dynamic randomisation will be carried out
by computer where the chance of referral to the pro-
gram and a stay at the centre will be reduced accord-
ingly as fewer resources are available to provide care
and fewer places in the centre are available.
Blinding
Treatment allocation is by definition un-blinded, but
since the hospital based reactivation care program is in
fact the usual care provided in the intervention hospital
it is possible to maximize blinding of data collectors by
describing the three offered health care programs as
usual care in all communications, thereby concealing
296 patients completed questionnaires at 
3 month follow up (T1) 
204 elderly excluded (49 died; 155 
dropped out/unable to complete 
questionnaire/other loss to follow 
up) 
500 patients completed questionnaires 
at time of hospital admission (T0) 
 
526 elderly 
Excluded (refused/terminally 
ill/died/Dutch language 
problems/not present at 
ward/cognitively unable/asleep/too 
ill/admission less than 48 hours) 
1026 persons registered and 
approached for study  
940 elderly (47%) not 
registered/approached 
(Reasons: Unknown, patient not 
present or not found, other practical 
problems)  
Inflow elderly 65+ admitted to the 
hospital (N=1966)  
12 month follow up measurements 
(to be finalized end of 2011) 
Figure 1 Flow chart pilot study.
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treatment allocation. Furthermore, blinded analyses of
data will take place when possible.
Data collection
There is no clear consensus on the time period during
which effects of interventions on physical functioning
and quality of life will be maintained. In some studies
effects were present at six to twelve months after the
start of the intervention, with the largest effect present
around three months [24,26]. Therefore, main data col-
lection of patient and caregiver outcomes takes place at
time of hospital admission (T0), three months after hos-
pital admission (T1) and twelve months after hospital
admission (T2). Trained research nurses and students
 
                Random 
               (dynamic) 
Triage 2 
NPI-Q  3 
MMSE  27 
Acutely or electively admitted elderly patients 
(65 years or older) 
                Triage 1  
            ISAR-HP  1              
                  
 Elderly at risk (= eligible for treatment with  
intervention program) 
(Informed consent for study asked) 
Patients excluded: 
- score of 0 on ISAR-HP 
- too ill /terminally ill 
- Dutch language problems 
- not present at ward /asleep 
- cognitively unable 
Patient refusals to participate 
 
± 400 elderly with indication for stay at 
the centre for prevention and 
reactivation 
N =  700 elderly included in 
program treatment only  
(mix of persons with/without indication 
centre stay) 
N =  200 elderly  
program + centre 
N = 200 elderly 
 program - centre  
T0 (baseline), T1 (3 month follow up), T2 (12 months follow up) measurements 
Figure 2 Flow chart intervention hospital.
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will administer questionnaires to patients by means of
interviews at T0, T1 and T2. Furthermore, informal
caregivers will receive paper questionnaires sent by mail.
Patient and caregiver outcome measures will then be
compared between the three hospitals. In addition a sur-
vey is administered among personnel of the three
hospitals at one time during the second half of the
inclusion period. Additional triage, outcomes, process,
and cost information is collected from patient files and
hospital ICT systems at time of discharge, during the
intervention and in retrospect. Based on the pilot results
we expect around 60% of patients analysable at 3 month
Triage 1 
ISAR-HP  1               
Elderly at risk 
(Informed consent for study asked) 
Patient refusals to participate 
 
T0 (baseline), T1 (3 month follow up), T2 (12 month follow up) measurements 
      N =  900 elderly 
       Included in study as control group 
Acutely or electively admitted elderly 
patients (65 years or older) 
Patients excluded: 
- score of 0 on ISAR-HP 
- too ill /terminally ill 
- Dutch language problems 
- not present at ward /asleep 
- cognitively unable 
Figure 3 Flow chart control hospitals.
Table 1 Data collection of patient and informal caregiver: demographics and triage
Evaluation Variables and+ instruments Data collection methods Data collection times Notes:
T0 T1 T2
General
Patient Demographics
MDS (age, ethnicity, SES, education) Interview patient X X X Partly at T1 and T2
Patient hospital files X incl info hospital ICT
Informal caregiver Demographics
MDS (relation to patient, SES etc) Mailed paper questionnaire X X X Partly at T1 and T2
Triage
Patient Risk for functional loss
ISAR-HP Interview patient X
MMSE (cognitive functioning) Interview patient X
NPI-Q (neuro-psychiatric functioning) Phone interview informal caregiver X
* T0 = within 48 hours of hospital admission; T1 = 3 months after hospital admission; T2 = 12 months after hospital admission; MDS = Minimal Data Set; ISAR-HP
= Identification Seniors At Risk (Hospitalized Patients); MMSE = Mini Mental State Examination; NPI-Q = Neuro-psychiatric Index;
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follow up. Loss to follow up is minimized by making
house calls and interviewing the patients in person [51].
Tables 1, 2, 3, 4 and 5 show a complete overview of out-
come variables and data collection instruments for
demographics and triage (table 1), effect evaluation
(tables 2 and 3), process evaluation (table 4) and cost
evaluation (table 5).
Demographics and triage (table 1)
Triage: identification of elderly at risk for functional
loss Triage data is gathered within 48 hours of hospital
admission in order to identify elderly at risk for
functional loss at an early stage. Based on the pilot
results the Identification of Seniors At Risk-hospitalized
patients (ISAR-HP) is chosen as the main triage instru-
ment in order to achieve information on a combination
of factors that have shown to be important in predicting
functional loss. The ISAR HP questionnaire is adminis-
tered to the patient and consists of four questions on
education and need of help with travelling, walking or
help with housekeeping in the period before admission
to the hospital [46]. A person is considered at risk for
functional loss and is therefore eligible for treatment
Table 2 Effect evaluation: Data collection of patient outcome variables
Patient outcome variables + instruments Data collection methods Data collection times Notes:
T0 T1 T2
Quality of life
SF-20 Interview patient X X X 5 items part of MDS
EQ-5D (6D) Interview patient X X X Part of MDS
SPF_IL Interview patient X X
Physical performance
Katz -15 Interview patient X X X Part of MDS
Short Physical Performance Battery “Do” test patient X X
LAPAQ (physical activity) Interview patient X X
Cognitive/psycho/social performance
NPI (neuro-psychiatric functioning) Interview caregiver X X X
MMSE (cognitive functioning) Interview patient X X X Short MMSE (T1 + T2)
Geriatric Depression Scale (depression) Interview patient X X X
Global Deterioration Scale (dementia) Phone interview inf. caregiver X X X
Loneliness scale Gierveld (social) Interview patient X
Intramural Residence Medical registries X
(Re-)admission hospital/nursing home Interview patient/caregiver X X
Mortality Medical registries X X
Patient self management
SMA-S Interview patient X X
*T0 = within 48 hours of hospital admission; T1 = 3 months after hospital admission; T2 = 12 months after hospital admission; * MDS = Minimal Data Set; SF-20
= Short Form 20; EQ6D = EuroQol; SPF-IL = Social Production Function questionnaire; SPPB = Short Physical Performance Battery; LAPAQ = LASA physical activity
questionnaire; MMSE = Mini Mental State Examination; NPI = neuro-psychiatric index;; GeDS = Geriatric Depression Scale; GloDS = Global Deterioration Scale;;
SMA-S = Self Management Ability Scale.
Table 3 Effect evaluation: Data collection of informal caregiver outcome variables
Informal caregiver outcome variables + instruments Data collection methods Data collection times Notes
T0 T1 T2
Quality of life
EQ-6D Mailed paper questionnaire X X X Part of MDS
SF20 Mailed paper questionnaire X X X 5 items part of MDS
Carer QoL Mailed paper questionnaire X X X Part of MDS
Burden of care
ARS (objective) Mailed paper questionnaire X X X Part of MDS
Questions on time spent on care tasks Mailed paper questionnaire X X X
CSI (subjective) Mailed paper questionnaire X X X
SRBS (subjective) Mailed paper questionnaire X X X Part of MDS
*T0 = within 48 hours of hospital admission; T1 = 3 months after hospital admission; T2 = 12 months after hospital admission; * MDS = Minimal Data Set; SF-20
= Short Form 20; EQ6D = EuroQol; GeDS = Geriatric Depression Scale;; ARS = Activity restriction scale; CSI = Caregiver strain index; SRBS = Self-rated burden
scale.
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with the program if he/she scores one or higher on the
ISAR HP. This is a different score from the originally
set cut off score of 2 or higher as is stated in the paper
written by Buurman et al (2010), and can be explained
by the differences in characteristics and diagnoses of the
studied population. In addition, the NPI-Q and MMSE
are administered in order to identify elderly who are eli-
gible for an additional stay at the centre for prevention
and reactivation as part of the program. Patients will be
considered eligible for a stay at the reactivation centre
when they score 2 or higher on the ISAR HP and/or 3
or higher on the NPI-Q and/or 27 or lower on the
MMSE. The Neuropsychiatric index (NPI-Q) is the vali-
dated short version of the NPI [49]. It aims to identify
neuropsychiatric symptoms present in the patient in the
last month by means of twelve symptoms (e.g. delusions,
aggression, hallucinations) and also measures the emo-
tional burden for the caregiver. The NPI is administered
to the primary informal caregiver of the patient by
means of a telephone interview at time of hospital
admission. The Mini Mental State Examination (MMSE)
measures cognitive functioning by means of interviewing
the patient using questions on orientation in time and
space, short-term and middle-term memory, compre-
hension and other cognitive dimensions [50,52].
Demographics Data on demographics (e.g. age, socioe-
conomic status, marital status, and gender) is gathered
at T0, T1 and T2 by means of the Minimal Data Set
(MDS) and hospital registries. The MDS is developed in
light of the national program elderly care in the Nether-
lands and aims to compare elderly persons as well as
their caregivers participating in different projects in the
Netherlands by measuring demographics, quality of life,
ADL functioning, experienced health and health care
utilization (patient-level) as well as demographics,
experienced health and burden of care, quality of life,
and objective burden of care (informal caregiver level).
The MDS is a combination of (parts of) validated ques-
tionnaires and is administered by trained research
nurses and trained students (e.g. medical students or
other students who have experience with research and/
or elderly care), who interview patients at T0, T1 and
T2. The data is collected from informal caregivers by
means of mailed paper questionnaires, which are self-
administered by informal caregivers and then sent back
to researchers. A reminder including an extra copy of
the questionnaire is sent to informal caregivers if they
did not send back the first questionnaire. Additional
data on demographics as well as data for other elements
of the evaluation (e.g. medication, diagnosis, specialist
consults) is collected from medical registries after hospi-
tal discharge.
Effect evaluation (tables 2 and 3)
All outcome data of the patient are collected by the
same means as the MDS described above.
Quality of life (patient) The EuroQol (EQ6D) is admi-
nistered to measure quality of life among patients and
their caregivers. It is part of the MDS and will be used
to calculate cost-utilities of health care [53].
The Dutch version of the SF-20 is administered and
aims to score 6 sub-dimensions such as physical func-
tioning, social functioning and experienced health [54].
The SF-20 is chosen since it is quick to administer and
many of its questions are already part of the MDS. The
SF-20 has shown good test-retest reliability and accepta-
ble convergent and discriminative validity for a group of
elderly persons, even though some precaution is advised
in using the questionnaire with elderly people living at
Table 4 Process evaluation: Data collection of process outcome variables
Outcome variables and instruments Data collection methods Data
collection
times
Notes
T0 T1 T2
Patient experiences with quality of care
PACIC Interview patient X X
(H)CAPHS Interview patient X
Caregiver experiences with quality of care
SASC - adapted for elderly care (+ own formulation additional questions) Mailed paper questionnaire X
Process of care delivery hospital
Process indicators (own formulation) Medical registers X + time after hospital discharge
Process of care delivery professional view
TCI (+ own formulation additional questions) Mailed paper questionnaire Last months inclusion period
ACIC (only partly) Mailed paper questionnaire Last months inclusion period
RCSP Mailed paper questionnaire Last months inclusion period
* T0 = within 48 hours of hospital admission; T1 = 3 months after hospital admission; T2 = 12 months after hospital admission * PACIC = Patient Assessment of
Chronic Illness Care; (H)CAPHS = (Hospital) Consumer Assessment of Healthcare Providers and Systems; SASC = Satisfaction with Stroke Care Questionnaire; TCI =
Team Climate Inventory; ACIC = Assessment of Chronic Illness Care; RCSP = Relational Coordination Survey for Professionals.
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Table 5 Cost effectiveness evaluation: Data collection health care volumes and prices
Outcome variables Data collection methods Data
collection
times
Notes
T0 T1 T2
Health care volumes
Period hospital admission: Hospital registries Time of
hospital
discharge
+ during inclusion
- amount of hospital days (days admitted) Hospital registries Time of
hospital
discharge
- total days/time admitted at ICU Hospital registries Time of
hospital
discharge
- amount of consults medical/paramedical Hospital registries Time of
hospital
discharge
- amount of large scans and diagnostics Hospital registries Time of
hospital
discharge
- amount of large treatments/operations Hospital registries Time of
hospital
discharge
- wrong bed days Hospital registries Time of
hospital
discharge
- amount of days admitted Hospital registries Time of
hospital
discharge
- amount of consults medical/paramedical Hospital registries, interviews personnel Time of
hospital
discharge
+ during inclusion
- time/amount of multidisciplinary
meetings
Hospital registries, interviews personnel Time of
hospital
discharge
+ during inclusion
Health care utilization patient in periods
before and after hospital stay
Interview patient and mailed paper
questionnaire primary caregiver
X X X
- homecare/nursing home/etc
Average time per consult Interviews professionals (sample) During
inclusion
period
Amount informal care MDS + questionnaire informal caregiver X X X Amount in hours
Amount (multidisciplinary) coordination Interviews professionals Amount in hours
Health care prices
price per hospital day DBC information + manual cost research Retrospective Similar calculations for prices hospital,
CPH, care hotels etc.
price per day/hour admitted at ICU DBC information + manual cost research
price of consults medical/paramedical DBC information + manual cost research
price of large scans and diagnostics DBC information + manual cost research
price of large treatments/operations DBC information + manual cost research
costs of home care/other care Integral costs per product cluster Retrospective
costs informal care by primary caregiver Market price/missed wages & time Retrospective
travel costs (average) Literature Retrospective
*T0 = within 48 hours of hospital admission; T1 = 3 months after hospital admission; T2 = 12 months after hospital admission.
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home [55]. The short version of the Social Production
Function Scale SPF-IL scale measures social well-being
by means of the dimensions “affection”, “behaviour con-
firmation” and “status” as well as physical well-being by
means of the dimensions “comfort” and “stimulation”
[56].
Physical functioning (patient) The Katz-15 index of
activities of daily living measures function over time by
means of questions on several domains such as bathing,
dressing, toileting, transferring, continence and feeding
[57,58]. The LAPAQ (LASA Physical Activity Question-
naire) is an interview administered questionnaire mea-
suring frequency and duration of activities such as
household activities, walking, gardening and sports [59].
The SSPB (short physical performance battery) is an
objective physical performance test consisting of
repeated chair stands (number of stands and amount of
time standing), balance testing (three different stands),
and walking (2.44 meters). This test is necessary in
order to see if the results from the subjective physical
performance tests are in agreement with measured
objective physical capabilities [60,61].
Cognitive and neuropsychiatric functioning (patient)
The NPI and MMSE (see triage for explanation) are
administered to measure cognitive and neuro-psychiatric
functioning over time, with the short version of the
MMSE being administered at follow up instead of the
longer version that was administered at time of hospital
admission. Nevertheless, the results are still comparable
using existing and tested transformation scores. The Glo-
bal Deterioration Scale (GDS) measures a patient’s stage
of dementia by means of 7 levels, from 1 (normal func-
tioning) to 7 (very serious dementia) and is administered
to the informal caregiver of the patient [62].
Social and psychological functioning (patient) The
Geriatric Depression Scale (GDS-15) identifies and mea-
sures functional as well as mood symptoms of depression
[63]. The GDS-15 has been validated in geriatric inpati-
ents as well as in primary care and community-living
elderly [64,65]. The Loneliness scale consists of 11 ques-
tions and measures social functioning of the patient [66].
Self-management (patient) The SMA-S (Self Manage-
ment Ability Scale) measures the ability of a person to
manage his/her own general daily life activities in the
past months. It contains items on several subjects such
as activities the patient initiates; activities the patient
starts now but expects to benefit from later; general
activities; combining activities; the success or failure of
activities; and dealing with adverse experiences [67].
Quality of life (caregiver) The carer quality of life
questionnaire (Carer QoL) measures quality of life of
caregivers and is part of the MDS [68]. The EuroQol is
also administered to the caregiver as part of the MDS
(see Quality of Life patients).
Burden of care (caregiver) Objective burden of care for
the caregiver is measured using the Activity Restriction
Scale [69] and additional questions on objective burden
of care [70,71]. Subjective burden of care is measured
with the Self Rated Burden Scale and Caregiver Strain
Index or CSI [72,73].
Process evaluation (table 4)
The process evaluation will look at process indicators
thereby showing the extent to which the new program
leads to better structure and process of care in compari-
son with other usual forms of geriatric care in two other
hospitals in the same region (e.g. improvements in coor-
dination between care-providers, patient logistics, infor-
mation logistics and support). In addition, the process
evaluation will focus on how and to what extent the
program is actually implemented according to plan.
This requires measuring instruments that are sensitive
for specific interventions and which are connected with
the expected alternations in the outcomes of care for
the elderly and caregiver. In order to do this, sub-
domains of the care process from a patient, caregiver
and professional point of view will be measured. In
addition, qualitative data is gathered to explain quantita-
tive outcomes. Described processes and provided inter-
ventions will be linked to outcomes in order to provide
a complete description of the evaluation of this transi-
tion project.
Process of care (patients) Patient experiences with
delivered care are measured at T1 by means of the
Patient Assessment of Chronic Illness Care (PACIC)
questionnaire, and consists of questions on care received
in the last 3 months [74]. In addition, specific experi-
ences with hospital care delivered during total hospital
stay around T0 are measured with the (Hospital) Consu-
mer Assessment of Healthcare Providers and Systems
((H)CAHPS), which consists of questions on treatment
by nurses and doctors, hospital environment, experi-
ences with hospital stay as well as discharge from the
hospital, and general appreciation for the hospital [75].
Registering process indicators involves a continuous
measurement of the care provided to the elderly and
their caregiver. At this time it does not appear possible
to make use of an Electronic Patient Dossier (EPD) in
all three hospitals. Therefore, process indicators will be
collected partly from existing registrations. The remain-
ing indicators are collected by research nurses and stu-
dents. Insight into the care process is provided by
covering the topics of ‘determining vulnerability’; ‘pro-
vided medical care (diagnostics and treatments)’ and
‘the extent of multidisciplinary meetings’.
Experiences quality of care (caregiver) The SASC
(Satisfaction with Stroke Care Questionnaire) originally
measures patient satisfaction with stroke care. For
current research, it has been adapted to caregiver
Asmus-Szepesi et al. BMC Geriatrics 2011, 11:36
http://www.biomedcentral.com/1471-2318/11/36
Page 11 of 17
satisfaction with the care for vulnerable elderly after dis-
charge. It covers subjects on both the acute and chronic
phase of care: experienced caregiver respect and infor-
mation provision during elderly hospital stay; the
amount of caregiver support and information provision
after elderly discharge [76,77]..
Process of care (professional) The TCI (Team Climate
Inventory) has been used as an improvement tool for
assessing team function to identify areas that could be
improved. It contains 14 items on several team dimen-
sions such as: task orientation and support for innova-
tion [78]. The ACIC (Assessment of Chronic Illness
Care) is a practical quality-improvement tool to evaluate
the delivery of care for chronic illness in six areas: com-
munity linkages; self-management support; decision sup-
port; delivery system design; information systems and
organisation of care [79]. The RCSP (Relational Coordi-
nation Survey for Professionals) measures the relational
dynamics of coordinating work. The self-administered
questionnaire contains 8 items. Different professionals
are asked how frequently, timely and accurately they
solve problems and share goals with other professionals
while treating vulnerable elderly [80].
Qualitative process measures Qualitative measures will
complement the quantitative data collection, thereby
strengthening the study design by providing the mixed
method component mentioned earlier. Qualitative mea-
sures will provide additional in-depth information on
the context in which the implementation of care and
interventions takes place (structure). An audit study
based on expert opinion and literature will provide
information on general quality of care (e.g. by means of
showing/evaluating differences and similarities in the
care and interventions that are provided in the three
hospitals). Furthermore, a fidelity study will collect
information on the differences between planned and
actual implementation of care and interventions in the
hospitals (is care implemented as it should be by the
professionals?). Finally, case studies by means of qualita-
tive interviews with professionals as well as observations
within the hospitals will provide further information and
insight as they provide a context in which quantitative
outcomes can be placed.
Cost-effectiveness evaluation (table 5)
A cost-utility analysis will compare cost differences
(incremental costs) of provided health care in the three
hospitals with the difference in health effects measured
in quality adjusted life years (QALYs). QALYs combine
alterations in quantity and quality of life (mortality and
morbidity) into a combined generic instrument. Data on
quality of life will be measured by means of the EQ6D
and SF20 for patients and by means of the EQ6D, Car-
erQoL and SF-20 for the primary informal caregiver (see
effect evaluation). Cost information is gathered by
means of hospital information systems, patient files and
questionnaires for both patient and primary caregiver at
baseline (T0), after three months (T1) and after 12
months (T2). A societal perspective is used; taking into
account both direct and indirect costs within as well as
outside health care. Data collection on utilization of
care in hospital (nursing days, diagnostic and therapeu-
tic activities and out-patient visits), nursing home (days),
rehabilitation (admissions/outpatient), and home care
(care hours according to product clusters) will take
place centrally, according to a standard method, by
means of standardized files and standard cost diaries as
well as through patient and caregiver questionnaires
Data analysis
Triage
Data will be gathered on risk factors for functional
decline and predictive models for functional decline at 3
and 12 months can be developed using multivariate
regression techniques and data from control settings.
The quality of the predictive models will be assessed by
explained variance for continuous outcome measures
and by ROC-curves for dichotomous outcome measures.
The quality of the model that fits the program eligibility
criteria will be compared to models with other risk fac-
tors involved and/or other cut-off points on the triage
instruments. This way the added value of another triage
method can be objectively assessed. These analyses were
already partly done using preliminary pilot study results
but will be repeated using final results of the main eva-
luation study. Furthermore, main study results will be
used to evaluate the validity of the model(s) with inter-
nal validation techniques (bootstrapping) and cross vali-
dation between the three settings whereby each setting
acts as a test-population for model(s) developed in the
other settings [81].
Effect evaluation and process evaluation
Effects and process evaluation of the hospital based
reactivation care program Corrections will take place
by means of ‘analysis of covariance’ for baseline differ-
ences in determinants between the locations that could
explain differences in functioning or quality of life. Mul-
tiple regression analysis will be administered for various
outcome variables such as linear regression for continu-
ous outcomes; logistic regression for dichotomous out-
comes; proportional odds regression for orderly
outcomes and Cox proportional hazards regression for
events that occur over time (such as death). Analysis of
outcomes at three and twelve months will take into
account dependency of these outcomes within persons.
The degree of exposure to integrated, multidisciplinary
care within the intervention location (process evalua-
tion) will also be correlated with effect measurements in
order to see whether greater exposure leads to greater
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effects. Regression analysis will trace sub-group effects
and an interaction term will be included in the model,
between type of hospital and sub group (e.g. elderly at
high risk for functional loss in comparison to elderly at
relatively lower risk for functional loss).
Effects and process evaluation of the centre for pre-
vention and recovery A randomised controlled trial
will be analyzed according to the “intention to treat”
principle. The process evaluation will study which
treatments are carried out in exactly which way. Since
differences in case mix and treatment regiments that
differ from the program can confound the relation
between the program and its expected effects, analysis
will be corrected for these possible confounders. For
example, data regarding diagnoses of elderly at admis-
sion and discharge will be collected and quantitative,
clinical treatment data is collected during intake which
is focused on medical diagnosis in order to correct for
differences in treatment regiments. The randomisation
leads to balance between arms of the randomised con-
trolled trial in observed and unobserved predictors of
functional decline. Important baseline characteristics
are taken into account in analyses to correct for imbal-
ance that might occur by coincidence, thereby increas-
ing power.
Cost-effectiveness evaluation
Primary outcome measure is costs per QALY. A cost-
utility analysis will compare cost differences (incremen-
tal costs) with the difference in health effects measured
in QALYs. In order to calculate costs, the volume of
care will be linked to the actual, integrated cost prices
per medical service [82]. Net costs per nursing day will
be calculated as well as the costs for diagnostics and
therapy with help from the manual of cost research in
economic evaluations [83] and will be judged for usabil-
ity according to recent DBC-information. Wrong bed
days will be estimated according to the method of Van
Straten [84]. The extra costs of a stay at the centre (e.g.
training, availability specialist care doctors and nurses,
mobilization, extra physiotherapy etc) in comparison
with the usual geriatric care provided in the program
will be measured, making a distinction between once-
only costs and structural costs [85]. Integrated costs per
day nursed at the centre will be calculated with aid of
the activity base costing method [82]. Data on person-
nel, material costs, diet-related costs, accommodation
and overheads will be accessed using centre registries
and information systems, and extra information is col-
lected through regular observation and self-registration
of professional activities. Integrated costs per hour, per
product cluster, will be used for home-care. For the
remaining extramural care (general practitioner care,
physiotherapy, social services etc.) costs will be assessed
with information from cost manual and recent cost-
price research. Costs are discounted at a constant dis-
count rate of 4% per year. Future health effects are dis-
counted at a constant discount ratio of 1.5% per year.
Net savings could occur on balance during hospital care,
whilst a stay at the reactivation centre as well as home
care will lead to use of additional means. This valance
of savings and extra costs cannot be indicated in
advance. It is expected that continuity of care will possi-
bly lead to considerable savings [86].
Discussion
The aim of this evaluation study is to compare out-
comes, processes and cost effectiveness of three different
healthcare programs provided for “at risk” elderly
whereby a new ‘hospital based reactivation care pro-
gram’ in the intervention hospital will be compared to
the usual care provided in two control hospitals.
Strengths
First of all, this study uses a mixed methods design of
quantitative and qualitative measures that provide infor-
mation on three elements as stated by Donabedian [87]:
structural issues (e.g. materials, personnel, organization
and coordination of care), processes (e.g. activities of
professional in diagnosing and treating the patient) and
patient and caregiver outcomes such as physical func-
tioning and quality of life. According to Donabedian,
the combination of these elements allows for better
interpretation of findings, as one method may
strengthen interpretation in cases where another method
cannot explain variances or outcomes. Qualitative data
may generate further hypotheses that may be explained
by quantitative process and outcome data. It can also
provide a context within which outcomes can be
explained more in-depth. Secondly, a pilot study was
conducted at the intervention hospital before imple-
menting the program, which optimised beforehand the
triage for selecting patients to be included in the main
study as well as the power calculations and the practical
implementation of the main study. Several practical and
implementation problems were encountered in the pilot
study (e.g. logistics within hospital, personal communi-
cation with hospital personnel etc), making it possible
to prevent similar problems and sources of bias when
conducting the main study. Within the cohort study,
dynamic randomisation will be implemented in order to
prevent extra bias and missing data per questionnaire.
Furthermore, loss to follow up will be minimized by
conducting personal interviews through house calls at
three months and 12 months after hospital admission.
Finally, the evaluation will be conducting a cost-effec-
tiveness study, which will improve/increase current
knowledge on the feasibility of implementing transition
programs such as the one evaluated here.
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Weaknesses
This study is mainly a cohort study and not a rando-
mised controlled trial (except for the evaluation of a
stay at the centre for prevention and reactivation).
Nevertheless a cohort study seems our best option for
several reasons: Firstly, during hospital treatment, con-
tamination of a control group would be inevitable within
one hospital since the same personnel will be treating
patients from different groups at the same departments
[88]. Secondly, the new program will be the standard
care provided in the intervention hospital thereby mak-
ing randomisation within the hospital not possible.
Furthermore, randomisation of treatments between hos-
pitals is not possible since each hospital already has its
own standard provided care. Thirdly, during the follow
up period after hospital discharge people already have
their own regular general practitioner (GP) whose prac-
tice is usually close to the patient’s home and who is
familiar with the patients health and history, making it
unrealistic to randomize patients among GP’s [88] or
home care organizations as well as other first line prac-
titioners. Finally, by conducting a prospective cohort
study we aim to investigate health care as provided in a
real life situation, thereby improving the generalisability
of the study.
Another possible weakness of this study might be the
fact that transitions within the three hospitals unrelated
to the study may influence outcomes (e.g. at the time of
writing this protocol plans exist for starting up specia-
lized clinical geriatric care in the St. Franciscus Gasthuis
in light of implementation of national guidelines on
elderly care). This may alter differences in levels of
health care provided by the hospitals over time thereby
influencing outcome and process results. Nevertheless,
these changes reflect how health care transitions evolve
in real life situations, making the outcomes very valuable
nonetheless. They will therefore be monitored closely by
means of our quantitative and qualitative process eva-
luation. To describe the program we will use a metho-
dological approach that combines qualitative and
quantitative (mixed) research methods, enabling a thor-
ough and comprehensive evaluation of care for elderly
at risk for hospital related functional loss. The introduc-
tion of complex, multi component interventions such as
this program is sensitive to an array of influences such
as details of implementation and context [89,90] and as
such calls for embracing a wide range of scientific meth-
odologies. Such a wide range of scientific methodologies
helps to obtain information on both mechanisms and
contexts, adds to the knowledge on the feasibility and
costs of different forms of integrated health care, and
highlights the factors that are likely to influence the suc-
cess and failure of integrated health care for elderly at
risk for hospital related functional loss.
Clinical implications
The results of the study will help determine the most
effective way of identifying and treating at risk elderly
who are admitted in the hospital in order to prevent
unnecessary hospital related functional loss among this
group and keep them as independent as possible for as
long as possible after they are discharged. In addition,
the study may show effective ways to lower the burden
of care for primary informal caregivers of elderly
patients at risk for functional loss as well as improve
their quality of life. Furthermore, the results will
increase knowledge on practical issues of implementing
a transition in health care and on ways to improve coor-
dination between first and second line care.
Research implications
By comparing costs, effects and processes of different
levels of integrated health care programmes offered in
three hospitals, this study will extend our knowledge on
how to prevent hospital related functional loss among
at-risk elderly patients in a more cost effective way. This
in turn may lead to further research on creating and
evaluating similar (improved) integrated health care pro-
grams thereby strengthening the health care offered to
elderly patients at risk for hospital related functional
loss at both a regional and national level.
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